Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study

OBJECTIVE: This study aims to explore the ability of betahistine to inhibit weight gain and abnormal lipid metabolism in patients with chronic schizophrenia. METHODS: A comparison study of betahistine or placebo therapy was conducted for 4 weeks in 94 patients with chronic schizophrenia, who were ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Luyuan, Liang, Weiye, Wang, Yongqian, Fan, Ning, zhang, Qi, Bian, Yun, Yang, Fude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984272/
https://www.ncbi.nlm.nih.gov/pubmed/36874957
http://dx.doi.org/10.2147/NDT.S392770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984272/
https://www.ncbi.nlm.nih.gov/pubmed/36874957
http://dx.doi.org/10.2147/NDT.S392770

Ejemplares similares